These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3885291)

  • 1. Amino acid precursors for the treatment of attention deficit disorder, residual type.
    Wood DR; Reimherr FW; Wender PH
    Psychopharmacol Bull; 1985; 21(1):146-9. PubMed ID: 3885291
    [No Abstract]   [Full Text] [Related]  

  • 2. An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type.
    Reimherr FW; Wender PH; Wood DR; Ward M
    Am J Psychiatry; 1987 Aug; 144(8):1071-3. PubMed ID: 3300376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tyrosine on attention deficit disorder with hyperactivity.
    Eisenberg J; Asnis GM; van Praag HM; Vela RM
    J Clin Psychiatry; 1988 May; 49(5):193-5. PubMed ID: 3284877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenfluramine treatment of childhood attention deficit disorder with hyperactivity: a preliminary report.
    Donnelly M; Rapoport JL; Ismond DR
    Psychopharmacol Bull; 1986; 22(1):152-4. PubMed ID: 3523573
    [No Abstract]   [Full Text] [Related]  

  • 5. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning.
    Brown RT; Wynne ME; Slimmer LW
    J Clin Psychiatry; 1984 Nov; 45(11):473-6. PubMed ID: 6386794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperactive children with D-phenylalanine.
    Zametkin AJ; Karoum F; Rapoport JL
    Am J Psychiatry; 1987 Jun; 144(6):792-4. PubMed ID: 3296793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of attention deficit disorder with DL-phenylalanine.
    Wood DR; Reimherr FW; Wender PH
    Psychiatry Res; 1985 Sep; 16(1):21-6. PubMed ID: 3903813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
    Wender PH
    J Clin Psychiatry; 1998; 59 Suppl 7():76-9. PubMed ID: 9680056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drug trials in attention deficit disorder.
    Rapoport JL; Zametkin A; Donnelly M; Ismond D
    Psychopharmacol Bull; 1985; 21(2):232-6. PubMed ID: 3923528
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind trials with stimulants for hyperactivity.
    McLaughlin JF; Tso Y
    Pediatrics; 1980 Sep; 66(3):481-2. PubMed ID: 6999449
    [No Abstract]   [Full Text] [Related]  

  • 12. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder.
    Bilici M; Yildirim F; Kandil S; Bekaroğlu M; Yildirmiş S; Değer O; Ulgen M; Yildiran A; Aksu H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):181-90. PubMed ID: 14687872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid supplementation as therapy for attention deficit disorder.
    Nemzer ED; Arnold LE; Votolato NA; McConnell H
    J Am Acad Child Psychiatry; 1986 Jul; 25(4):509-13. PubMed ID: 3528266
    [No Abstract]   [Full Text] [Related]  

  • 17. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.
    Akhondzadeh S; Tavakolian R; Davari-Ashtiani R; Arabgol F; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):841-5. PubMed ID: 12921918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bach flower remedies used for attention deficit hyperactivity disorder in children--a prospective double blind controlled study.
    Pintov S; Hochman M; Livne A; Heyman E; Lahat E
    Eur J Paediatr Neurol; 2005; 9(6):395-8. PubMed ID: 16257245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atomoxetine for the treatment of attention-deficit/hyperactivity disorder].
    Davids E; Gastpar M
    Fortschr Neurol Psychiatr; 2004 Oct; 72(10):586-91. PubMed ID: 15472782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonidine for treatment of attention-deficit/hyperactivity disorder.
    Med Lett Drugs Ther; 1996 Dec; 38(989):109-10. PubMed ID: 8957471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.